View Item 

Show simple item record

The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review

dc.contributor.authorCash, Brooks D.en_US
dc.contributor.authorSchoenfeld, Philip S.en_US
dc.contributor.authorChey, William D.en_US
dc.date.accessioned2010-06-01T19:22:05Z
dc.date.available2010-06-01T19:22:05Z
dc.date.issued2002-11en_US
dc.identifier.citationCash, Brooks D . ; Schoenfeld, Philip; Chey, William D . (2002). "The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review." The American Journal of Gastroenterology 97(11): 2812-2819. <http://hdl.handle.net/2027.42/72511>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72511
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12425553&dopt=citationen_US
dc.description.abstractThe aim of this study was to determine the pretest probability of organic GI disease and the accuracy of diagnostic tests for organic GI disease in patients who meet symptom-based criteria for irritable bowel syndrome (IBS). METHODS : After a comprehensive literature search for studies examining the accuracy of diagnostic tests for organic GI disease among patients who meet symptom-based criteria for IBS, two independent observers qualitatively assessed the methodology of selected studies and extracted data. Data on the pretest probability of organic GI disease in this population and the accuracy of currently recommended diagnostic tests were converted to descriptive tables. RESULTS : Among patients meeting symptom-based criteria for IBS, the pretest probability of inflammatory bowel disease, colorectal cancer, or infectious diarrhea is less than 1%. Currently recommended diagnostic tests rarely identify organic GI disease in patients fulfilling symptom-based criteria for IBS. However, the pretest probability of celiac disease in patients meeting symptom-based criteria for IBS was 10 times higher than the prevalence of celiac disease in the general population. CONCLUSION : There is insufficient evidence to recommend the routine performance of a standardized battery of diagnostic tests in patients who meet symptom-based criteria for IBS. Based upon the increased pretest probability of celiac disease, routine performance of serological tests for celiac disease may be useful in this patient population, though additional study is needed in this area.en_US
dc.format.extent66304 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2002 by Am. Coll. of Gastroenterologyen_US
dc.titleThe utility of diagnostic tests in irritable bowel syndrome patients: a systematic reviewen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivision of Gastroenterology, University of Michigan School of Medicine, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumVA Center for Excellence in Health Care Research, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationotherDivision of Gastroenterology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USAen_US
dc.identifier.pmid12425553en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72511/1/j.1572-0241.2002.07027.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2002.07027.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceDrossman D.A., Whitehead W.E., Camilleri M.. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997; 112: 2120 – 2137.en_US
dc.identifier.citedreferenceSandler R.S.. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990; 99: 409 – 415.en_US
dc.identifier.citedreferenceTalley N.J., Gabriel S.E., Harmsen W.S., et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736 – 1741.en_US
dc.identifier.citedreferenceGoodman C., Cronin K., Gemmen E., et al The burden of gastrointestinal diseases. Bethesda, MD: American Gastroenterological Association, 2001: 2 – 65.en_US
dc.identifier.citedreferenceManning A.P., Thompson W.G., Heaton K.W., et al. Towards a positive diagnosis of the irritable bowel syndrome. Br Med J 1978; 2: 653 – 654.en_US
dc.identifier.citedreferenceThompson W.G., Dotewall G., Drossman D.A., et al. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92 – 95.en_US
dc.identifier.citedreferenceThompson W.G., Longstreth G.F., Drossman D.A., et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 ( suppl II ): II43 – II47.en_US
dc.identifier.citedreferenceVanner S.J., Depew W.T., Paterson W.G., et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastrenterol 1999; 94: 2803 – 2807.en_US
dc.identifier.citedreferenceSaito Y.A., Locke G.R., Talley N.J., et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 2679 – 2681.en_US
dc.identifier.citedreferenceThompson W.G., Irvine E.J., Pare P., et al. Functional gastrointestinal disorders in Canada: First population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47: 225 – 235.en_US
dc.identifier.citedreferenceMearin F., Badia X., Balboa A., et al. Irritable bowel syndrome prevalence varies enormously depending upon the employed diagnostic criteria: Comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001; 36: 1121 – 1122.en_US
dc.identifier.citedreferenceChey W.D., Olden K., Carter E.. Utility of the Rome I and Rome II criteria for IBS in US women. Am J Gastroenterol. 2002 ( in press ).en_US
dc.identifier.citedreferenceDrossman D.A.. An integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther 1999; 13 ( suppl 2 ): 3 – 14.en_US
dc.identifier.citedreferenceCamilleri M., Prather C.M.. The irritable bowel syndrome: Mechanisms and a practical approach to management. Ann Intern Med 1992; 116: 1001 – 1008.en_US
dc.identifier.citedreference15. American Gastroenterological Association Medical Position Statement Irritable bowel syndrome. Gastroenterology 1997; 112: 2118 – 2119.en_US
dc.identifier.citedreferenceSchmulson M.W., Chang L.. Diagnostic approach to the patient with irritable bowel syndrome. Am J Med 1999; 107: 20S – 26S.en_US
dc.identifier.citedreferenceCamilleri M.. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652 – 668.en_US
dc.identifier.citedreferenceSchoenfeld P.S., Guyatt G., Hamilton F., et al. An evidence-based approach to gastroenterology diagnosis. Gastroenterology 1999; 116: 1230 – 1237.en_US
dc.identifier.citedreferenceJaeschke R., Guyatt G.H., Sackett D.L.. Users guide to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence based medicine working group. JAMA 1994; 271: 389 – 391.en_US
dc.identifier.citedreferenceHasler W.L., Owyang C.. Irritable bowel syndrome. In: Yamada T., ed. Textbook of gastroenterology. Philadelphia: JB Lippincott, 1991: 1696 – 1716.en_US
dc.identifier.citedreferenceLijmer J.G., Mol B.W., Heisterkamp S., et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999; 282: 1061 – 1066.en_US
dc.identifier.citedreferenceIrwig L., Tostetson A.N., Gastonis C., et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994; 120: 667 – 676.en_US
dc.identifier.citedreferenceHamm L.R., Sorrells S.C., Harding J.P., et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999; 94: 1279 – 1282.en_US
dc.identifier.citedreferenceTolliver B.A., Herrera J.L., DiPalma J.A.. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994; 89: 176 – 178.en_US
dc.identifier.citedreferenceMacIntosh D.G., Thompson W.G., Patel D.G., et al. Is rectal biopsy necessary in irritable bowel syndrome?. Am J Gastroenterol 1992; 87: 1407 – 1409.en_US
dc.identifier.citedreferenceFrancis C.Y., Duffy J.N., Whorwell P.J., et al. Does routine ultrasound enhance diagnostic accuracy in irritable bowel syndrome?. Am J Gastroenterol 1996; 91: 1348 – 1350.en_US
dc.identifier.citedreferenceSanders D.S., Carter M.J., Hurlstone D.P., et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling the ROME II criteria referred to secondary care. Lancet 2001; 358: 1504 – 1508.en_US
dc.identifier.citedreferencePimentel M., Chow E.J., Lin H.C.. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95: 3503 – 3506.en_US
dc.identifier.citedreferenceHelfand M., Redfern C.C.. Screening for thyroid disease: An update. Ann Intern Med 1998; 129: 144 – 158.en_US
dc.identifier.citedreferenceScrimshaw N.S., Murray E.B.. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr 1988; 48 ( suppl 4 ): 1079 – 1159.en_US
dc.identifier.citedreferenceBourlioux P., Pochart P.. Nutritional and health properties of yogurt. World Rev Nutr Diet 1988; 56: 217 – 258.en_US
dc.identifier.citedreferenceTolliver B.A., Jackson M.S., Jackson K.L., et al. Does lactose maldigestion really play a role in the irritable bowel syndrome?. J Clin Gastroenterol 1996; 23: 15 – 17.en_US
dc.identifier.citedreferenceOtte J.J., Larsen L., Andersen J.R.. Irritable bowel syndrome and symptomatic diverticular disease—Different diseases. Am J Gastroenterol 1986; 81: 529 – 531.en_US
dc.identifier.citedreferenceCiclitira P.J.. AGA technical review on celiac sprue. Gastroenterology 2001; 120: 1526 – 1540.en_US
dc.identifier.citedreferenceWahnschaffe U., Ullrich R., Riecken E.O., et al. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001; 121: 1329 – 1338.en_US
dc.identifier.citedreferenceRostami K., Kerckhaert J., Tiemessen R., et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: Disappointing in clinical practice. Am J Gastroenterol 1999; 94: 888 – 894.en_US
dc.identifier.citedreferenceTursi A., Brandimarte G., Giorgetti G., et al. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol 2001; 96: 1507 – 1510.en_US
dc.identifier.citedreferenceHawkey C.J.. Irritable bowel syndrome clinical trial design: Future needs. Am J Med 1999; 107: 98S – 102S.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1572-0241.2002.07027.x.pdf
Size:
64.75KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.